>I saw part of a news item on tv last evening [US] that said something about
>a new treatment for age related macular degeneration [wet]. I did not get
[quoted text clipped - 6 lines]
>
>-Aula
http://www.mercurynews.com/mld/mercurynews/14946814.htm
Hey there.. i'm an ophthalmologist. i saw your posting., the new drug
is Lucentis from Genentec. its only for patients with wet macular
degeneration which accounts for only 10% of all macular degeneration
patients. it has no impact on those diagnosed earlier in life as it
is used only when the wet form occurs, and that could be at any age..
eyedoc
> I saw part of a news item on tv last evening [US] that said something about
> a new treatment for age related macular degeneration [wet]. I did not get
[quoted text clipped - 6 lines]
>
> -Aula
LarryDoc - 03 Jul 2006 05:36 GMT
> Hey there.. i'm an ophthalmologist. i saw your posting., the new drug
> is Lucentis from Genentec. its only for patients with wet macular
> degeneration which accounts for only 10% of all macular degeneration
> patients. it has no impact on those diagnosed earlier in life as it
> is used only when the wet form occurs, and that could be at any age..
But it is important to note that those 10% with wet MD account for 90%
of patients who loose their vision from all types of MD and that number
is over a million people. It is likewise important to note that a not
insignificant number of patients with dry MD "convert" to the wet form
over time.
Lucentis, and it's sister anti-cancer drug Avastin are examples of one
of the new medicines that are revolutionizing the treatments of serious
human pathology.
LB, O.D.
Aula,
Please go to
http://www.mdsupport.org/
...has extensive discussions of these drugs and side effects.
Don W.